Improvements in Glycemic Control Achieved by Altering the t(max) Setting in the iLet(®) Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial

INTRODUCTION: We investigated the safety of, and glucose control by, the insulin-only configuration of the iLet(®) bionic pancreas delivering fast-acting insulin aspart (faster aspart), using the same insulin-dosing algorithm but different time to maximal serum drug concentration (t(max)) settings,...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Steven J., Balliro, Courtney, Ekelund, Magnus, El-Khatib, Firas, Graungaard, Tina, Greaux, Evelyn, Hillard, Mallory, Jafri, Rabab Z., Rathor, Naveen, Selagamsetty, Raj, Sherwood, Jordan, Damiano, Edward R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266971/
https://www.ncbi.nlm.nih.gov/pubmed/34146238
http://dx.doi.org/10.1007/s13300-021-01087-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266971/
https://www.ncbi.nlm.nih.gov/pubmed/34146238
http://dx.doi.org/10.1007/s13300-021-01087-x

Ejemplares similares